nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7—Rifampicin—leprosy	0.116	0.129	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.116	0.129	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0956	0.106	CbGbCtD
Alprazolam—CYP3A7—Dapsone—leprosy	0.0956	0.106	CbGbCtD
Alprazolam—CYP3A5—Thalidomide—leprosy	0.0897	0.0997	CbGbCtD
Alprazolam—CYP3A5—Rifampicin—leprosy	0.0869	0.0966	CbGbCtD
Alprazolam—CYP3A5—Dapsone—leprosy	0.0717	0.0797	CbGbCtD
Alprazolam—CYP2C9—Thalidomide—leprosy	0.0602	0.0669	CbGbCtD
Alprazolam—CYP2C9—Rifampicin—leprosy	0.0583	0.0648	CbGbCtD
Alprazolam—CYP2C9—Dapsone—leprosy	0.0481	0.0535	CbGbCtD
Alprazolam—CYP3A4—Rifampicin—leprosy	0.0339	0.0377	CbGbCtD
Alprazolam—CYP3A4—Dapsone—leprosy	0.028	0.0311	CbGbCtD
Alprazolam—Hangover—Thalidomide—leprosy	0.00535	0.0536	CcSEcCtD
Alprazolam—Altered state of consciousness—Thalidomide—leprosy	0.00273	0.0273	CcSEcCtD
Alprazolam—Hostility—Thalidomide—leprosy	0.00228	0.0228	CcSEcCtD
Alprazolam—Sexual dysfunction—Thalidomide—leprosy	0.00225	0.0225	CcSEcCtD
Alprazolam—Galactorrhoea—Thalidomide—leprosy	0.00194	0.0195	CcSEcCtD
Alprazolam—Menstrual disorder—Thalidomide—leprosy	0.00185	0.0185	CcSEcCtD
Alprazolam—Stupor—Thalidomide—leprosy	0.00169	0.0169	CcSEcCtD
Alprazolam—Hyperaesthesia—Thalidomide—leprosy	0.00161	0.0161	CcSEcCtD
Alprazolam—Nasopharyngitis—Dapsone—leprosy	0.0016	0.016	CcSEcCtD
Alprazolam—Muscular weakness—Dapsone—leprosy	0.00158	0.0158	CcSEcCtD
Alprazolam—Influenza—Dapsone—leprosy	0.00154	0.0155	CcSEcCtD
Alprazolam—Photosensitivity reaction—Dapsone—leprosy	0.00141	0.0141	CcSEcCtD
Alprazolam—Musculoskeletal stiffness—Thalidomide—leprosy	0.0014	0.0141	CcSEcCtD
Alprazolam—Dyskinesia—Thalidomide—leprosy	0.00134	0.0134	CcSEcCtD
Alprazolam—Coordination abnormal—Thalidomide—leprosy	0.00128	0.0128	CcSEcCtD
Alprazolam—Depressed level of consciousness—Thalidomide—leprosy	0.00122	0.0122	CcSEcCtD
Alprazolam—Tinnitus—Dapsone—leprosy	0.00115	0.0115	CcSEcCtD
Alprazolam—Gynaecomastia—Thalidomide—leprosy	0.00113	0.0113	CcSEcCtD
Alprazolam—Lightheadedness—Thalidomide—leprosy	0.00113	0.0113	CcSEcCtD
Alprazolam—Mental disability—Thalidomide—leprosy	0.00109	0.011	CcSEcCtD
Alprazolam—Euphoric mood—Thalidomide—leprosy	0.00108	0.0108	CcSEcCtD
Alprazolam—Vision blurred—Dapsone—leprosy	0.00101	0.0102	CcSEcCtD
Alprazolam—Libido decreased—Thalidomide—leprosy	0.000987	0.00988	CcSEcCtD
Alprazolam—Increased appetite—Thalidomide—leprosy	0.000974	0.00975	CcSEcCtD
Alprazolam—Amnesia—Thalidomide—leprosy	0.000974	0.00975	CcSEcCtD
Alprazolam—Vertigo—Dapsone—leprosy	0.000967	0.00968	CcSEcCtD
Alprazolam—Lethargy—Thalidomide—leprosy	0.000934	0.00935	CcSEcCtD
Alprazolam—Diplopia—Thalidomide—leprosy	0.000915	0.00916	CcSEcCtD
Alprazolam—Pain in extremity—Thalidomide—leprosy	0.000915	0.00916	CcSEcCtD
Alprazolam—Osteoarthritis—Thalidomide—leprosy	0.000915	0.00916	CcSEcCtD
Alprazolam—Disturbance in sexual arousal—Thalidomide—leprosy	0.000908	0.00909	CcSEcCtD
Alprazolam—Affect lability—Thalidomide—leprosy	0.0009	0.00902	CcSEcCtD
Alprazolam—Mood swings—Thalidomide—leprosy	0.000867	0.00868	CcSEcCtD
Alprazolam—Ataxia—Thalidomide—leprosy	0.00086	0.00861	CcSEcCtD
Alprazolam—Tachycardia—Dapsone—leprosy	0.000857	0.00858	CcSEcCtD
Alprazolam—Liver function test abnormal—Thalidomide—leprosy	0.000845	0.00846	CcSEcCtD
Alprazolam—Breast disorder—Thalidomide—leprosy	0.000827	0.00828	CcSEcCtD
Alprazolam—Cramp muscle—Thalidomide—leprosy	0.000824	0.00825	CcSEcCtD
Alprazolam—Muscular weakness—Thalidomide—leprosy	0.000807	0.00808	CcSEcCtD
Alprazolam—Insomnia—Dapsone—leprosy	0.000794	0.00795	CcSEcCtD
Alprazolam—Dysphagia—Thalidomide—leprosy	0.000791	0.00792	CcSEcCtD
Alprazolam—Influenza—Thalidomide—leprosy	0.000791	0.00792	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Thalidomide—leprosy	0.000735	0.00736	CcSEcCtD
Alprazolam—Pollakiuria—Thalidomide—leprosy	0.00073	0.00731	CcSEcCtD
Alprazolam—Photosensitivity reaction—Thalidomide—leprosy	0.000722	0.00723	CcSEcCtD
Alprazolam—Weight increased—Thalidomide—leprosy	0.00072	0.0072	CcSEcCtD
Alprazolam—Gastrointestinal pain—Dapsone—leprosy	0.000718	0.00719	CcSEcCtD
Alprazolam—Weight decreased—Thalidomide—leprosy	0.000715	0.00716	CcSEcCtD
Alprazolam—Infestation—Thalidomide—leprosy	0.000705	0.00706	CcSEcCtD
Alprazolam—Drowsiness—Thalidomide—leprosy	0.000705	0.00706	CcSEcCtD
Alprazolam—Infestation NOS—Thalidomide—leprosy	0.000705	0.00706	CcSEcCtD
Alprazolam—Depression—Thalidomide—leprosy	0.000703	0.00704	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000699	0.007	CcSEcCtD
Alprazolam—Abdominal pain—Dapsone—leprosy	0.000694	0.00695	CcSEcCtD
Alprazolam—Body temperature increased—Dapsone—leprosy	0.000694	0.00695	CcSEcCtD
Alprazolam—Sweating—Thalidomide—leprosy	0.000676	0.00677	CcSEcCtD
Alprazolam—Epistaxis—Thalidomide—leprosy	0.000665	0.00666	CcSEcCtD
Alprazolam—Hepatitis—Thalidomide—leprosy	0.000633	0.00634	CcSEcCtD
Alprazolam—Hypoaesthesia—Thalidomide—leprosy	0.00063	0.0063	CcSEcCtD
Alprazolam—Urinary tract disorder—Thalidomide—leprosy	0.000625	0.00626	CcSEcCtD
Alprazolam—Oedema peripheral—Thalidomide—leprosy	0.000623	0.00624	CcSEcCtD
Alprazolam—Urethral disorder—Thalidomide—leprosy	0.00062	0.00621	CcSEcCtD
Alprazolam—Erythema multiforme—Thalidomide—leprosy	0.000598	0.00599	CcSEcCtD
Alprazolam—Eye disorder—Thalidomide—leprosy	0.000591	0.00592	CcSEcCtD
Alprazolam—Tinnitus—Thalidomide—leprosy	0.00059	0.00591	CcSEcCtD
Alprazolam—Cardiac disorder—Thalidomide—leprosy	0.000587	0.00588	CcSEcCtD
Alprazolam—Angiopathy—Thalidomide—leprosy	0.000574	0.00575	CcSEcCtD
Alprazolam—Mediastinal disorder—Thalidomide—leprosy	0.00057	0.00571	CcSEcCtD
Alprazolam—Chills—Thalidomide—leprosy	0.000568	0.00569	CcSEcCtD
Alprazolam—Vomiting—Dapsone—leprosy	0.000558	0.00559	CcSEcCtD
Alprazolam—Mental disorder—Thalidomide—leprosy	0.000554	0.00555	CcSEcCtD
Alprazolam—Malnutrition—Thalidomide—leprosy	0.000551	0.00552	CcSEcCtD
Alprazolam—Headache—Dapsone—leprosy	0.00055	0.00551	CcSEcCtD
Alprazolam—Tension—Thalidomide—leprosy	0.000541	0.00541	CcSEcCtD
Alprazolam—Nervousness—Thalidomide—leprosy	0.000535	0.00536	CcSEcCtD
Alprazolam—Back pain—Thalidomide—leprosy	0.000533	0.00534	CcSEcCtD
Alprazolam—Muscle spasms—Thalidomide—leprosy	0.00053	0.0053	CcSEcCtD
Alprazolam—Nausea—Dapsone—leprosy	0.000522	0.00522	CcSEcCtD
Alprazolam—Vision blurred—Thalidomide—leprosy	0.000519	0.0052	CcSEcCtD
Alprazolam—Tremor—Thalidomide—leprosy	0.000516	0.00517	CcSEcCtD
Alprazolam—Ill-defined disorder—Thalidomide—leprosy	0.000511	0.00512	CcSEcCtD
Alprazolam—Agitation—Thalidomide—leprosy	0.000506	0.00507	CcSEcCtD
Alprazolam—Angioedema—Thalidomide—leprosy	0.000503	0.00504	CcSEcCtD
Alprazolam—Malaise—Thalidomide—leprosy	0.000497	0.00497	CcSEcCtD
Alprazolam—Vertigo—Thalidomide—leprosy	0.000495	0.00496	CcSEcCtD
Alprazolam—Syncope—Thalidomide—leprosy	0.000494	0.00495	CcSEcCtD
Alprazolam—Palpitations—Thalidomide—leprosy	0.000487	0.00487	CcSEcCtD
Alprazolam—Loss of consciousness—Thalidomide—leprosy	0.000484	0.00485	CcSEcCtD
Alprazolam—Convulsion—Thalidomide—leprosy	0.000477	0.00478	CcSEcCtD
Alprazolam—Chest pain—Thalidomide—leprosy	0.000469	0.0047	CcSEcCtD
Alprazolam—Arthralgia—Thalidomide—leprosy	0.000469	0.0047	CcSEcCtD
Alprazolam—Myalgia—Thalidomide—leprosy	0.000469	0.0047	CcSEcCtD
Alprazolam—Anxiety—Thalidomide—leprosy	0.000467	0.00468	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000466	0.00466	CcSEcCtD
Alprazolam—Discomfort—Thalidomide—leprosy	0.000463	0.00464	CcSEcCtD
Alprazolam—Dry mouth—Thalidomide—leprosy	0.000459	0.00459	CcSEcCtD
Alprazolam—Confusional state—Thalidomide—leprosy	0.000453	0.00454	CcSEcCtD
Alprazolam—Oedema—Thalidomide—leprosy	0.00045	0.0045	CcSEcCtD
Alprazolam—Infection—Thalidomide—leprosy	0.000447	0.00447	CcSEcCtD
Alprazolam—Shock—Thalidomide—leprosy	0.000442	0.00443	CcSEcCtD
Alprazolam—Nervous system disorder—Thalidomide—leprosy	0.000441	0.00442	CcSEcCtD
Alprazolam—Tachycardia—Thalidomide—leprosy	0.000439	0.00439	CcSEcCtD
Alprazolam—Skin disorder—Thalidomide—leprosy	0.000437	0.00437	CcSEcCtD
Alprazolam—Hyperhidrosis—Thalidomide—leprosy	0.000435	0.00435	CcSEcCtD
Alprazolam—Anorexia—Thalidomide—leprosy	0.000429	0.00429	CcSEcCtD
Alprazolam—Hypotension—Thalidomide—leprosy	0.00042	0.00421	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Thalidomide—leprosy	0.00041	0.0041	CcSEcCtD
Alprazolam—Insomnia—Thalidomide—leprosy	0.000407	0.00407	CcSEcCtD
Alprazolam—Paraesthesia—Thalidomide—leprosy	0.000404	0.00404	CcSEcCtD
Alprazolam—Dyspnoea—Thalidomide—leprosy	0.000401	0.00401	CcSEcCtD
Alprazolam—Somnolence—Thalidomide—leprosy	0.0004	0.004	CcSEcCtD
Alprazolam—Dyspepsia—Thalidomide—leprosy	0.000396	0.00396	CcSEcCtD
Alprazolam—Decreased appetite—Thalidomide—leprosy	0.000391	0.00391	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Thalidomide—leprosy	0.000388	0.00389	CcSEcCtD
Alprazolam—Fatigue—Thalidomide—leprosy	0.000388	0.00388	CcSEcCtD
Alprazolam—Constipation—Thalidomide—leprosy	0.000385	0.00385	CcSEcCtD
Alprazolam—Feeling abnormal—Thalidomide—leprosy	0.000371	0.00371	CcSEcCtD
Alprazolam—Gastrointestinal pain—Thalidomide—leprosy	0.000368	0.00368	CcSEcCtD
Alprazolam—Urticaria—Thalidomide—leprosy	0.000357	0.00358	CcSEcCtD
Alprazolam—Abdominal pain—Thalidomide—leprosy	0.000355	0.00356	CcSEcCtD
Alprazolam—Body temperature increased—Thalidomide—leprosy	0.000355	0.00356	CcSEcCtD
Alprazolam—Hypersensitivity—Thalidomide—leprosy	0.000331	0.00332	CcSEcCtD
Alprazolam—Asthenia—Thalidomide—leprosy	0.000323	0.00323	CcSEcCtD
Alprazolam—Pruritus—Thalidomide—leprosy	0.000318	0.00319	CcSEcCtD
Alprazolam—Diarrhoea—Thalidomide—leprosy	0.000308	0.00308	CcSEcCtD
Alprazolam—Dizziness—Thalidomide—leprosy	0.000297	0.00298	CcSEcCtD
Alprazolam—Vomiting—Thalidomide—leprosy	0.000286	0.00286	CcSEcCtD
Alprazolam—Rash—Thalidomide—leprosy	0.000284	0.00284	CcSEcCtD
Alprazolam—Dermatitis—Thalidomide—leprosy	0.000283	0.00284	CcSEcCtD
Alprazolam—Headache—Thalidomide—leprosy	0.000282	0.00282	CcSEcCtD
Alprazolam—Nausea—Thalidomide—leprosy	0.000267	0.00267	CcSEcCtD
